Le LÚzard
Classified in: Business
Subject: STH

IIROC Trading Halt - BZ


VANCOUVER, BC, Nov. 30, 2021 /CNW/ - The following issues have been halted by IIROC:

Company: Benz Mining Corp.

TSX-Venture Symbol: BZ

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 4:48 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 21:05
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR ? Logitech International (SIX: LOGN) today announced financial results for the third quarter of Fiscal Year 2022, with strong growth in Pointing Devices, Keyboards & Combos and Gaming,...

at 21:00
Market Real Estate completed a lease at 1102 Pearl Street totaling 1,527 square feet with sustainable clothing brand Marine Layer. Marine Layer creates apparel made from recycled beechwood and upcycled clothing. Marine Layer is the latest lifestyle...

at 20:47
Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") is pleased to announce the distribution amounts per unit (the "Distributions") for its suite of covered call exchange traded funds (the "ETFs"), for the period ending January 31, 2022, as...

at 20:36
Horizons ETFs Management (Canada) Inc.á("Horizons ETFs") is pleased to announce the distribution amounts per unit (the "Distributions") for certain of its exchange traded funds (the "ETFs"), for the period ending January 31, 2022, as indicated in the...

at 20:00
Faircourt Asset Management Inc., as Manager of the Faircourt Funds (NEO:FGX), (NEO:FCS.UN), is pleased to announce the monthly distributions payable on the Shares and Trust Units of the below listed Funds. á Faircourt FundsTrading...

at 20:00
RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, recently announced positive results from the completion of its Phase II trial in China for Telitacicept in the treatment of primary Sj÷gren's syndromeá("pSS"). A total of 42...



News published on 30 november 2021 at 17:14 and distributed by: